Dexco

Aging Demographics And Markets Will Curb Prospects Yet Pave Recovery

AnalystLowTarget

Not Invested

Consensus Narrative from 10 Analysts

Published

31 Jul 25

Updated

31 Jul 25

AnalystLowTarget's Fair Value

R$6.00

3.5% undervalued

31 Jul

R$5.79

-28.1%

3.2%

Author's Valuation

R$6.0

3.5% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

R$6.0

3.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.74%

Paper and Forestry Products revenue growth rate

0.11%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

27.29%

Calculation

R$372.28m

Earnings '28

26.37x

PE Ratio '28

R$9.82b

Market Cap '28

R$9.82b

Market Cap '28

808.36m

No. shares '28

R$12.15

Share Price '28

R$12.15 Share Price '28

Discounted to 2025 @ 26.52% p.a.

R$6.00

Fair Value '25